Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study

Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study

The parasitic disease visceral leishmaniasis (VL) causes a significant burden of illness and death in India. The main drug used to treat VL, which is based on the chemical element antimony, stopped working well in about half of all patients in the late twentieth century. We hypothesised that arsenic...

Full description

Bibliographic Details
Main Authors: Perry, Meghan R., Prajapati, Vijay K., Menten, Joris, Raab, Andrea, Feldmann, Joerg, Chakraborti, Dipankar, Sundar, Shyam, Fairlamb, Alan H., Boelaert, Marleen, Picado, Albert
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346263/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346263/

Similar Items